A sustainable alternative to assess neuraxial blockade at a lower cost and reduced carbon footprint
Reduced use of consumables (e.g. ethyl chloride, saline sachets etc.)
Reduced cost
Reduced carbon footprint
Re-usable and durable
CoolStick
External dermatomal sensory level detector used to assess neuraxial blockade.
Class 1m medical device (ARTG No: 452506)
Reviews
CoolSticks were rolled out in Northumbria with positive feedback received from patients and the anaesthetic team. The financial and carbon savings are really impressive”
Dr Zoe Roberts
Northumbria NHS Trust, UK
“Our use of ethyl chloride has reduced by over 50% in the first six month period after the introduction of CoolSticks in the theatre.”
Brianna
Brighton